Company profile: Onward
1.1 - Company Overview
Company description
- Provider of an implantable neuro-stimulation system (INS) with real-time motion feedback and training tools to rehabilitate patients with neurological disorders, including spinal cord injury (SCI).
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Onward
Rapid Dose Therapeutics
HQ: Canada
Website
- Description: Provider of pharma-tech oral fast-dissolving drug delivery solutions, including QuickStrip for direct bloodstream delivery of pharmaceuticals and over-the-counter medicines; RDMx + QuickStrip for enabling delivery of large therapeutic molecules; Rapid Energy, Vitamin B12, and Melatonin QuickStrip products; and versions for elderly and pediatric patients needing simplified, rapid dosing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rapid Dose Therapeutics company profile →
Neuronetics
HQ: United States
Website
- Description: Provider of non-drug, non-invasive TMS therapies for mental health, including NeuroStar Advanced Therapy for major depressive disorder using precise magnetic stimulation, supported by the TrakStar HIPAA-compliant practice management system and features like MT Assist and Contact Sensing for accurate dosing and real-time treatment feedback.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neuronetics company profile →
Auspex Pharma
HQ: United States
Website
- Description: Provider of development and commercialization of novel medicines for orphan diseases, with product candidates addressing unmet needs in hyperkinetic movement disorders such as chorea associated with Huntington's disease; also a deuteration company developing therapeutics for depressive disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Auspex Pharma company profile →
Xanodyne
HQ: United States
Website
- Description: Provider of integrated specialty pharmaceutical products, developing and commercializing offerings in women's healthcare and pain management in the United States.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xanodyne company profile →
eNeura
HQ: United States
Website
- Description: Provider of non-invasive single-pulse transcranial magnetic stimulation (sTMS) devices and digital tools for migraine treatment and prevention, including the SAVI Dual Migraine Therapy device, SAVI Smart Diary for tracking treatment history and personalized patterns, and a dedicated support team for onboarding, optimizing results, monitoring progress, and managing prescription refills.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eNeura company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Onward
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Onward
2.2 - Growth funds investing in similar companies to Onward
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Onward
4.2 - Public trading comparable groups for Onward
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →